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Abstract: Objective: To develop and validate a risk score model for recognizing prediabetes among Indonesian adults in primary care.Methods: This
was a cross-sectional diagnostic study. After excluding subjects with diabetes from Indonesian National Basic Health Survey (INBHS) data set,
21,720 subjects who have completed fasting plasma glucose test and aged >18 years were selected for development stage. About 6,933 subjects were
selected randomly from INBHS for validation stage in different diagnostic criteria of prediabetes-based random plasma glucose. Logistic regression
was used to determine significant diagnostic variable and the receiver operating characteristic analysis was used to calculate area under the curve
(AUC), cutoff point, sensitivity, specificity, and predictive values.Results: Age, sex, education level, family history of diabetes, smoking habit, physical
activity, body mass index, and hypertension were significant variables for Indonesian Prediabetes Risk Score (INA-PRISC). The scoring range from 0
to 24, the AUCwas 0.623 (95% CI 0.616–0.631) and cutoff point of 12 yielded sensitivity/specificity (50.03%/67.19%, respectively). The validation
study showed the AUC was 0.646 (95% CI 0.623–0.669) and cutoff point of 12 yielded sensitivity/specificity (55.11%/65.81%, respectively).
Conclusion: INA-PRISC, which consists of eight demographical and clinical variables, is a valid and a simple prediabetes risk score in primary care.
Keywords: development, validation, risk score model, prediabetes, primary care
Introduction
Diabetes is one of the most common chronic diseases
found throughout the world, where the prevalence
continues to grow significantly. According to the Inter-
national Diabetes Foundation, in 2013 there were
approximately 382 million people with diabetes world-
wide, and this is expected to rise to 592 million by 2035.
Indonesia is one of the ten most populous countries with
diabetes, where in 2013 the number of diabetics aged
20–79 years is 8.5 million, and estimates in 2035 the
prevalence will increase to 14.1 million [1].
The Indonesian National Basic Health Survey
(INBHS) 2013 found that diabetes prevalence in Indo-
nesia is increasing, with the age-adjusted prevalence of
adults (aged 15 years and above) increased from 5.7% in
2007 to 6.9% in 2013; however, only one third (2.4%)
were diagnosed by health-care providers, 4.5% were
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categorized as undiagnosed diabetes. Moreover, the prev-
alence of prediabetes in Indonesian adult population is
also increasing dramatically, from 10.2% in 2007 to 36.6%
in 2013 [2]. From prediabetes alone, the number of people
with diabetes in Indonesia will increase by one third, hence
prediabetes is a major public health problem [3].
Prediabetes is a condition where blood glucose is above
normal, but it does not measure up to the criteria of
diabetes mellitus. Conditions included in prediabetes are
impaired glucose tolerance (IGT), impaired fasting glucose
(IFG), or both [4]. For patients who carry both IGT and
IFG, cumulative incidence of diabetes in the period of
6 years is 65%, compared with the person with normal
blood glucose level [3]. Thus, identifying those individuals
with prediabetes becomes crucial and cost-effective [5–7].
The traditional diabetes screening methods, including
the fasting plasma glucose (FPG), the 2-h oral glucose
tolerance test (OGTT) or HbA1c test, are invasive, incon-
venient, and expensive [7], especially for large populations
like Indonesia. This is also one of the important reasons
why there are a large number of diabetic patients remaining
undiagnosed. Until now, as far as we know, there is no
scoring system for prediabetes available in Indonesia. Seek-
ing a simple, reliable, and cost-effective screening method,
such as a prediabetes risk score that can be easily conducted
in clinical or community settings by primary care physicians
(PCPs) is very important at this time. While the role of
PCPs is essential in the early detection and prevention of
prediabetes and diabetes, it has become even more impor-
tant in Indonesia since Universal Health Coverage began
in 2014. PCPs are the basis of a tiered health care to make
health care cost-effective and cost-efficient [8].
Many diabetes risk score questionnaires have been
developed and validated in various countries and ethnic
groups to identify patients at high risk of diabetes, but
only few for prediabetes, and most have been designed for
Caucasians in developed countries, and there are only a
few scoring systems for Asian populations [9]. Risk scores
derived from certain populations may not be applicable to
other ethnic groups [10]. Therefore, there is a need to
establish a prediabetes risk score for the Indonesian adult
population. Moreover, having their own score may make
PCPs more motivated to use the method [11].
This paper aims to develop and validate Indonesian
Prediabetes Risk Score (INA-PRISC) model based on
INBHS 2013 data set.
Research Design and Methods
Data source and subjects
This study consists of two stages which were (1) devel-
opment stage, using the INBHS FPG data set to develop
prediabetes scoring system model and (2) validation
stage, using the random plasma glucose (RPG) data set
to validate the model.
The INBHS is a nationwide, community-based survey
which designed in the national level, provinces, and
districts/cities. It was a cross-sectional health examina-
tion and survey regularly conducted by The National
Institute of Health Research and Development, Ministry
of Health in Indonesia. The purpose of the national
survey is to monitor the Indonesians’ health status, to
evaluate the achievement of national health, and to plan
the next national health programs based on the evidence
in INBHS [2]. To date, INBHSs have been performed in
the years 2007 (INBHS I), 2010 (INBHS II), and 2013
(INBHS III). The INBHS consists of four different
surveys: a health interview survey, a health behavior
survey, a health examination survey, and a nutrition
survey. The survey encompasses household information
including all family members, family income, health
financing, access to the health care, pharmacy and tradi-
tional health, mental health, community empowerment
program, sanitation, and environmental health. Individ-
ual information consist of communicable and non-
communicable diseases, genetics and family history, injuries,
eye health, mouth and dental health, disabilities, knowl-
edge, attitude and behavior toward health, mother and
child health, immunization, nutrition, etc. Quality assur-
ance of the survey and the data management had been
performed by independent bodies. Similar to another
national health survey, each INBHS consists of indepen-
dent sets of individuals from the Indonesian population.
All individuals were randomly selected from 12,000
Blocks Census randomly assigned in 33 provinces and
497 districts and cities in Indonesia. Details of the surveys
available in the INBHS protocol book that can be down-
load in the official website [12].
Subjects aged above 18 years (35,374 individuals) were
selected for the study as sampling frame, assuming that the
risk of prediabetes started since childhood with the increas-
ing number of obesity in children in Indonesia [2]. Subjects
who were identified in the health interview survey with a
previous diagnosis of diabetes by a health-care professional
or who were taking insulin or oral anti-diabetes agents, or
have the classic sign and symptoms of diabetes (polyuria,
polyphagia, and polydipsia) were defined as having “known
diabetes,” and subjects who were first diagnosed with
diabetes by the survey were classified as having “undiag-
nosed diabetes” both were excluded from the study. Sub-
jects with missing data in key covariates were also excluded.
As results, we had 21,720 subjects who have completed
data analysis based on FPG test for development stage, and
6,933 subjects completed data analysis based on RPG test
for the validation stage.
Variables and measurements
We used demographics data including information on
age, sex, and level of education. We defined un-education
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for individuals who have never been to school and indi-
viduals who have not completed primary school; low
education for people who have primary school certificate,
and high education defined as people who have high
school certificate and above.
Family history of diabetes was restricted to first rela-
tives only, such as father, mother, or siblings, had diabe-
tes. Subjects were classified into smoking categories of
smoker (daily smoker and occasional smoker), and non-
smoker (never smoked, ex-occasional smoker, and
ex-daily smoker) by self-report.
Based on physical activity, subjects were divided into
heavy and moderate physical activity. Heavy physical
activity is an activity that is continuously doing at least
for 10 min until the pulse raised and breathing faster than
normal (e.g., draw water from well, mountain climbing,
sprinting, cutting trees, hoeing, etc.) for at least 3 days a
week and total activity time ≥1,500 MET-min. MET-
minute for physical activity is the length of time (minutes)
doing activity within 1 week multiplied by a weighting of
8 calories. Moderate physical activity (sweeping, mop-
ping, etc.) at least 5 days or more with total active
duration of 150 min in 1 week. Active is doing moderate
or heavy physical activities or both, whereas less active is
not doing moderate or heavy physical activities. Sedentary
activity is the behavior of a sitting or lying everyday both
in the workplace (working at the computer, reading,
etc.), at home (watching TV, playing games, etc.), on
the go/transport (buses, trains, and motor), but not
including bedtime, with cutoff point <3 h/day, 3–5.9
and ≥6 h/day for risky behavior.
Classification for body mass index (BMI) in this study
used the criteria for Asian populations which are 18.5–
22.9 kg/m2 defined as normal, 23.0–24.9 kg/m2 as
overweight, and 25.0 kg/m2 and above as obese [13].
Laboratory parameters, including FPG test were mea-
sured after overnight fasting, and RPG test based on ADA
standards. Prediabetes is fasting blood glucose level of
100–125 mg/dl (IFG) or blood glucose 2-h post glucose
load of 140–199 mg/dl (IGT) or both [4].
Subjects were diagnosed as hypertensive if they were
documented to have hypertension diagnosed by a physi-
cian or if they were taking anti-hypertensive medication,
or diagnosed as hypertensive in second measurement after
5-min rest by trained health-care nurse, based on
JNC-VIII classification for hypertension [systolic blood
pressure (SBP) ≥140 mmHg or diastolic blood pressure
(DBP) ≥90 mmHg] [14].
Statistical analysis
Subjects’ characteristics were summarized by descriptive
statistics, and expressed as proportions with categorical in
numbers and percentage. Chi-square tests were applied to
compare categorical variables. These procedures allow
users to specify primary sampling units, stratification
identification, and sampling weights in the statistical
procedures with 95% confidence interval (CI) and 5%
precision of the study. For model development, we
applied multiple logistic regression analysis with predia-
betes at the end point. We included the variables that
statistically significant in bivariate analysis based on their
p values and CI, and clinically significant by comparing
differences in the proportion of prediabetes in the study
with reference in minimal expected effect size. The
variables were considered clinically significant when the
proportion of the comparison group difference of
more than 1.
Backward elimination (deleting the covariate with the
largest p value, one at a time) was performed from the
initial model until we reached a final model with statisti-
cally significant covariates.
We double checked the final model to ensure that no
important covariates were omitted in this sequential
process. We intentionally used only categorized variables
that captured easy but relevant and validated health
information in the prediction model to develop a user-
friendly screening score. Sensitivity, specificity, and pre-
dictive values were calculated. The receiver operating
characteristic (ROC) with area under the curve (AUC)
was constructed to visually show the relationship between
true-positive (sensitivity) and specificity. The ROC curve
was also used to evaluate the performance of INA-PRISC
in discriminating prediabetes and normal individuals
[15]. We determined cutoff points as threshold and
define “risk” as very low risk (VLR), low risk (LR),
medium risk (MR), and high risk (HR) based on the
total score ranges of the cutoff points.
The scoring system was developed based on regression
coefficients multiplied by 10 and rounded to the nearest
integer to derive weights of the scores [16]. This scoring
system then performed in a questionnaire form that can
be used easily by health personnel in primary care.
To validate the prediabetes risk score, we evaluated
our scoring system by filling the questionnaire using data
set RPG of INBHS 2013 as external validation. Statistical
analyses were conducted to calculate sensitivity, specifici-
ty, predictive values, and AUC with 95% CI.
Results
Development stage of INA-PRISC
In developing the prediabetes scoring system, we used
Indonesian National Survey which comes from 33 pro-
vinces, represented by 21,720 complete data set, that
were analyzed gradually.
Table I illustrates the prevalence of prediabetes in
group data set based on socio-demographic characteris-
tics and variable predictors of the participants. Of 21,720
Fujiati et al.
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Table I Bivariate analysis of predictors for prediabetes in the development of INA-PRISC
Prediabetes Normal 95% CI
n % n % p value OR Min Max
1. Age
>55 years 2.431 52.6 2.187 47.4 <0.001 3.069 2.737 3.443
46–55 years 2.323 48.0 2.515 52.0 <0.001 2.550 2.275 2.859
36–45 years 2.330 39.7 3.538 60.3 <0.001 1.818 1.626 2.034
26–35 years 1.295 29.5 3.100 70.5 0.018 1.154 1.025 1.299
19–25 years 532 26.6 1.469 73.4 Reference
2. Sex
Male 3.878 44.5 4.830 55.5 <0.001 1.273 1.205 1.345
Female 5.033 38.7 7.979 61.3 Reference
3. Education level
Uneducation (never been to school/not
completed primary school)
2.510 49.2 2.590 50.8 <0.001 1.745 1.627 1.871
Low education (primary school certificate) 3.260 41.7 4.564 58.3 <0.001 1.286 1.208 1.369
High education (high school and above) 3.141 35.7 5.655 64.3 Reference
4. Diabetes history in first degree
Yes 124 50.8 120 49.2 0.002 1.492 1.159 1.921
No/unknown 8.787 40.9 12.689 59.1 Reference
5. Smoking habit
Yes (daily and occasional smoker) 2.920 45.8 3.454 54.2 <0.001 1.320 1.244 1.400
No (ex-daily, ex-occasional, and non-smoker) 5.991 39.0 9.355 61.0 Reference
6. BMI (kg/m2)
≥25 (obese) 2.706 43.4 3,526 56.6 <0.001 1.155 1.085 1.228
23–24.9 (overweight) 1.412 40.5 2.072 59.5 0.525 1.025 0.949 1.107
18.5–22.9 (normal) 4.793 39.9 7.211 60.1 Reference
7. High physical activity
No or ≤1,500 MET-min/week 5.298 39.2 8.215 60.8 <0.001 0.820 0.776 0.867
≥1,500 MET-min/week 3.613 44.0 4.594 56.0 Reference
8. Moderate physical activity
No or <150 min/week 1.238 45.0 1.514 55.0 <0.001 1.204 1.111 1.305
≥150 min/week 7.673 40.5 11.295 59.5 Reference
9. Physical activity classification
No or less active 353 39.5 541 60.5 0.049 0.866 0.751 0.999
High or moderate physical activity 5.830 40.3 8.647 59.7 <0.001 0.895 0.843 0.950
Both high and moderate physical activity 2.728 43.0 3.621 57.0 Reference
10. Sedentary lifestyle
≥6 h/day 1.940 39.6 2.960 60.4 0.059 0.932 0.866 1.003
3–5.9 h/day 3.834 41.6 5.389 58.4 0.716 1.011 0.951 1.076
<3 h/day 3.137 41.3 4.460 58.7 Reference
11. Diet fiber (fruits and vegetables)/day
<1 serving 1.770 41.7 2.476 58.3 0.515 1.062 0.885 1.275
1–<2 servings 3.805 40.7 5.538 59.3 0.816 1.021 0.856 1.218
(Continued)
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adults above 18 years old that underwent fasting blood
glucose test, a prevalence 41.0% of IFG were found.
Prediabetes tends to increase with age, more frequent in
males, more in active smokers. It occurred more in low
and uneducated subjects. It also increased in higher BMI
and higher blood pressure, i.e., SBP and DBP. But, in
subjects with sedentary activities more than 6 h, less than
3 h, and fiber-based diet, there were almost no
differences.
In the bivariate analysis, of 13 variables only 11 vari-
ables that were statistically significant with p value less
than 0.05 and clinically significant with odds ratio (OR)
more than 1 were included in the multivariate analysis.
The other variables were sedentary activity and fiber
consumption that have p value greater than 0.05 and
were excluded from the analysis.
Table II describes the final regression model. We
included eight predictor variables for prediabetes: they
were (1) age, (2) gender, (3) level of education, (4)
diabetes history in first degree, (5) smoker, (6) moderate
physical activity, (7) BMI, and (8) SBP. These variables
were predictors which used for INA-PRISC epidemio-
logical model. In daily practice, this epidemiological
model would very hard to implement, and because of
that, we simplified the epidemiological model into scor-
ing system as shown in Table III. Subsequently, for each
participant, the total scores were estimated by this scoring
rule. The total score of the participants ranged from 0 to
24 points. The minimum score 0 obtained when the
participant does not have risk factors, and maximum
score of 24 was obtained when the participant have all
the risk factors for prediabetes. The eight predictor
variables jointly yielded an AUC of 0.623 (95% CI
0.616–0.631) in the development model. A cut point of
12 of total score was selected as optimal point with the
optimal value both sensitivity of 50.03% (95% CI 48.98–
51.07) and specificity of 67.19% (95% CI 66.37–68.00).
We divided the risk of having prediabetes into four
categories. The observed prevalence of prediabetes
among very low-risk participants (0–6 points) was 28%
(1,767 out of 6,374 participants), 40% (2,686 out of
6,685 participants) among low risk (7–11 points), 51%
(4,249 out of 8,285 participants) among medium risk
(12–17 points), and 56% (209 out of 376 participants)
among high-risk participants (18–23 points) (Table IV).
Dichotomizing scale at, for example, 18 points (at <18
points the diagnosis was normal glucose and ≥18 it was
prediabetes) yielded a positive predictive value (PPV) of
55.59% and a negative predictive value (NPV) of 59.23%
(Table IV).
Validation stage of INA-PRISC
We assessed the performance of the INA-PRISC using the
RPG of INBHS 2013 complete data set (n= 6,933) as
external validation. The purpose of validation was to
evaluate the ability of generalizability of the risk score,
which provided accurate predictions in terms of calibration
and discrimination on a new subject from the identical
population with different clinical criteria, such as RPG. We
chose RPG data set considering that the RPG data set
drawn from the same population characteristics and clinical
history but different subjects with FPG data set.
Table I (Continued)
Prediabetes Normal 95% CI
n % n % p value OR Min Max
2–<3 servings 1.757 41.6 2.471 58.4 0.553 1.057 0.881 1.268
3–<4 servings 1.091 40.6 1.597 59.4 0.874 1.015 0.841 1.226
4–<5 servings 270 40.1 403 59.9 0.971 0.996 0.791 1.254
≥5 servings 218 40.2 324 59.8 Reference
12. SBP
≥160 mmHg 971 51.5 914 48.5 <0.001 2.013 1.820 2.225
140–159 mmHg 1.441 48.0 1.560 52.0 <0.001 1.750 1.609 1.904
120–139 mmHg 3.474 43.0 4.604 57.0 <0.001 1.430 1.343 1.521
<120 mmHg 3.025 34.5 5.731 65.5 Reference
13. DBP
≥100 mmHg 888 47.3 988 52.7 <0.001 1.451 1.314 1.603
90–99 mmHg 1.430 43.3 1.869 56.7 <0.001 1.235 1.140 1.338
80–89 mmHg 2.908 42.1 4.003 57.9 <0.001 1.173 1.101 1.249
<80 mmHg 3.685 38.2 5.949 61.8 Reference
Total 8.911 41.0 12.809 59.0
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In validation stage, we investigated the diagnostic
characteristics using a sample of risk questionnaire shown
in Table III. The optimal cutoff point for RPG was 12
resulted in overall test consistent results with AUC=
0.646 (95% CI 0.623–0.669), compared with FPG where
the optimal cutoff point is 12 and AUC= 0.623 (95% CI
0.614–0.629). This result shows that the questionnaires
filled out by participants in these two groups have similar
AUC values.
Using the formula of the questionnaire in Table III, we
could estimate participant’s probability of prediabetes
based on his or her demographic characteristics and
Table II Multivariate analysis of predictors for prediabetes and score assigned in the development of INA-PRISC
95% CI
Risk factors B (coefficient β) p value OR (Exp B) Min Max
Score
assigned*
Intercept −1.257
1. Age
>55 years 0.873 <0.001 2.393 2.108 2.716 9
46–55 years 0.735 <0.001 2.085 1.846 2.353 7
36–45 years 0.459 <0.001 1.582 1.409 1.777 5
26–35 years 0.074 0.225 1.077 0.955 1.215 1
19–25 years Reference 0
2. Sex
Male 0.083 0.048 1.087 1.001 1.181 1
Female Reference 0
3. Education level
Uneducation (never been to school/not
completed primary school)
0.267 <0.001 1.306 1.207 1.413 3
Low education (primary school certificate) 0.065 0.057 1.067 0.998 1.141 1
High education (high school and above) Reference 0
4. Diabetes history in first degree
Yes 0.314 0.017 1.369 1.057 1.774 3
No/unknown Reference 0
5. Smoking habit
Yes 0.227 <0.001 1.255 1.151 1.368 2
No Reference 0
6. Moderate physical activity
No or <150 min/week 0.094 0.030 1.098 1.009 1.196 1
≥150 min/week Reference 0
7. BMI for Asian population
≥25 (obese) 0.226 <0.001 1.253 1.171 1.341 2
23–24.9 (overweight) 0.066 0.103 1.069 0.987 1.157 1
18.5–22.9 (normal) Reference
8. Hypertension `
SBP ≥160 mmHg or DBP ≥100 mmHg 0.251 <0.001 1.285 1.152 1.434 3
SBP 140–159 mmHg or DBP 90–99 mmHg 0.191 <0.001 1.211 1.105 1.326 2
SBP 120–139 mmHg or DBP 80–89 mmHg 0.167 <0.001 1.182 1.107 1.262 2
SBP 120 mmHg and DBP 80 mmHg Reference
Based on the final regression model in the development data set, Indonesian National Basic Health Survey 2013 [n= 21.720; AUC= 0.623 (95% CI
0.616–0.631); Hosmer–Lemeshow test, p < 0.001]
*Beta coefficients were multiplied by 10 and rounded to the nearest integer to derive scores
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clinical profile. The observed prevalence of prediabetes
among very low-risk participants (0–6 points) was 3.6%
(90 out of 2,451 participants), 7.8% (156 out of 1,997
participants) among low risk (7–11 points), 12% (286 out
of 2,366 participants) among medium risk (12–17
points), and 13.4% (209 out of 376 participants) among
high-risk participants (18–23 points) (see Table IV).
Dichotomizing scale at, for example, 18 points (at <18
points the diagnosis was normal glucose and ≥18 it was
prediabetes) yielded a PPV of 13.45% and an NPV of
92.19% (Table IV). The overall prevalence of prediabetes
in RPG was 7.9% (548 out of 6,933 participants). Pre-
dictive values were affected by the prevalence of predia-
betes, as shown in Table IV.
Discussion
In this study, the prevalence of prediabetes in individuals
aged above 18 years was found to be 41% based on FPG
test results. At the INBHS 2013 report, IFG in the
population aged 15 years and above was 36.6%.
Table III Screening questionnaire for participants, recommended for use by health-care providers
Risk factors Individual data Score
1. Age
>55 years 9
46–55 years 7
36–45 years 5
26–35 years 1
19–25 years 0
2. Sex
Male 1
Female 0
3. Education level
Uneducation (never been to school/not completed primary school) 3
Low education (primary school certificate) 1
High education (high school and above) 0
4. Diabetes history in first degree
Yes 3
No/unknown 0
5. Smoking habit
Yes 2
No 0
6. Physical activity
No or <150 min/week 1
≥150 min/week 0
7. BMI
≥25 (obese) 2
23–24.9 (overweight) 1
18.5–22.9 (normal) 0
8. Hypertension
SBP ≥160 mmHg or DBP ≥100 mmHg 3
SBP 140–159 mmHg or DBP 90–99 mmHg 2
SBP 120–139 mmHg or DBP 80–89 mmHg 2
SBP 120 mmHg and DBP 80 mmHg
Total score
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Compared with other Asian countries, the prevalence of
prediabetes in Indonesia is quite high [17]. For that, we
developed a scoring system that is simple, easily use by a
health-care provider, does not require any blood assays,
and does not require a long time to identify individuals
who have a risk of prediabetes.
To date, most risk assessment scores for diabetes and
not many for prediabetes. We focus to identify prediabe-
tes, but when category high-risk subjects undergo con-
firmation test, we can also expect to find undiagnosed
diabetes. Thus, it is expected that there will be many case
findings for early treatment. As far as we know, our
prediabetes risk score model is the first model in Indo-
nesia. Other known scoring system is for undiagnosed
diabetes [18].
Prediabetes is a high-risk state for diabetes [19].
Around 8%–10% of people with prediabetes become
diabetic annually although conversion rate varies by pop-
ulation characteristics [4]. In the Diabetes Prevention
Program (DPP) Outcomes Study, progression estimates
have been similar: the annualized incidence was 11% [20].
Fortunately, prediabetes is now recognized as a reversible
condition that can be prevented from becoming diabetic.
Increase of awareness and risk stratification of individuals
with prediabetes may help physicians understand poten-
tial interventions that may help decrease the conversion
rate [21]. Many studies suggest that lifestyle intervention
may decrease the risk of prediabetes progressing to dia-
betes up to 58% [20, 22].
The prediabetes risk score will be used as a screening
tool that is cheap and easily performed on individuals who
appears to be healthy in general population to determine
the population at risk in accordance with the basic prin-
ciples of screening [23].
Comparing to other prediabetes studies that exist
today, INA-PRISC discrimination capability as measured
by ROC was 62.3% lower than another prediabetes risk
score. However, we found that one of the variables was
race/specific ethnicity which will be limit the generaliz-
ability of the model on specific population [24, 25], that
might not be relevant to our population.
INA-PRISC includes three non-modifiable risk fac-
tors: (1) age: IFG and IGT, varied in accordance with
ethnicity, but have something in common, that is, it is
more frequent in the older age group [26]; (2) history
with diabetes in first degree: study on different ethnic
groups reported that a family history of diabetes increased
the risk of having diabetes 2–6 times greater in those who
did not have family history of diabetes [27]; (3) sex: this
study showed that in Indonesia, IFG affected more in
males (44.5%) than females (38.7%). Consistent with
another study that stated IFG found more in males than
females [26].
Five modifiable factors included in INA-PRISC are (1)
smoking habit: exposure to both acute and chronic
nicotine could have negative effects on insulin action, inTa
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subjects who smoked before or smoked after the diagno-
sis of diabetes was performed with the occurrence of
insulin resistance [28]; (2) body weight: in East Asian
countries, diabetes occurred at a much lower BMI com-
pared with the US and European countries [29]; (3)
physical activity; (4) education; and (5) hypertension.
INA-PRISC could assess individual using modifiable
factors and not only from unmodifiable factors which
cannot be changed. These provide many opportunities
for prevention, such as lifestyle modification.
We performed external validation of INA-PRISC by
RPG. RPG recommended by the Screening for Impaired
Glucose Tolerance (SIGT) could be used to prompt
further evaluation with an OGTT. Discriminative effective-
ness of RPG evaluated by ROC analysis, defining OGTT
as the gold standard that identified ROCs 0.81 and
0.72 [30]. RPG is convenient, inexpensive, and commonly
used in primary care. INA-PRISC can be used as a cost-
effective and feasible screening tool for a large country like
Indonesia with a population of over 250 millions.
The strengths of this study include large sample size,
sex balance, range of age, and BMI, and taking into
consideration the education level as a variable that affect-
ed the subjects’ knowledge in deciding to have a healthy
lifestyle. However, the limitation of this study was the lack
of information on easily measurable risk factor that may
be important predictor of prediabetes, such as waist
circumference. This, unfortunately, precludes the chance
to investigate potentially important variable in the opti-
mum risk score. Among the modifiable risk factors that
played a substantial role in previous studies was obesity,
measured by BMI or waist circumference. Both BMI and
waist circumference were found to increase diabetes risk
at cutoff points suggested for Asian populations that are
lower than those used for people in Western countries
[31]. Therefore, further studies will be required to in-
crease the discriminative ability of INA-PRISC in recog-
nizing prediabetes in primary care.
Conclusion
INA-PRISC is a simple prediabetes scoring system to
identify people at high risk of developing diabetes in the
future. Given the resourcing issues required for laboratory
tests and the difficulty accessing such tests for rural and
remote populations, the INA-PRISC only includes items
that are easy to measure in primary care facilities through-
out Indonesia, thereby increasing the feasibility of
implementation.
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